This inventor holds 2 USPTO granted patents, plus 1 CIPO patent and 1 EPO patent. Top assignee: Innovent Biologics (Suzhou) Co., Ltd.. Active years: 2020-2021.
Company Filing History:
Years Active: 2020-2021
Title: De-Chao Michael Yu: Innovator in Cancer Therapeutics
Introduction
De-Chao Michael Yu is a prominent inventor based in Suzhou, China. He has made significant contributions to the field of cancer therapeutics, particularly through his work on PD-1 antibodies. With a total of 2 patents, his innovations are paving the way for new treatment options in oncology.
Latest Patents
Yu's latest patents focus on antibodies that bind to human programmed cell death 1 (PD-1). These inventions may be useful for treating cancer both alone and in combination with chemotherapy and other cancer therapeutics. His work in this area is crucial for developing more effective cancer treatments.
Career Highlights
De-Chao Michael Yu is associated with Innovent Biologics (Suzhou) Co., Ltd., where he continues to advance research in biopharmaceuticals. His expertise in antibody development has positioned him as a key figure in the fight against cancer.
Collaborations
Some of his notable coworkers include Cheng Chen and Xiaolin Liu, who contribute to the innovative environment at Innovent Biologics.
Conclusion
De-Chao Michael Yu's work in developing PD-1 antibodies represents a significant advancement in cancer treatment. His contributions are vital for improving therapeutic options for patients battling cancer.